Stephen L. Hauser, MD

Articles by Stephen L. Hauser, MD

Stephen L. Hauser, MD: Fenebrutinib and BTK Inhibition in Progressive MS

September 26th 2020

The director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that can be used across the spectrum of MS, and the role disease progression plays early on.

Stephen L. Hauser, MD: Increasing Understanding of Disease Progression in MS

ByStephen L. Hauser, MD

September 23rd 2020

The director of the UCSF Weill Institute for Neuroscience spoke to the advantages of having agents that can be used across the spectrum of MS, and the role disease progression plays early on.

Stephen L. Hauser, MD: Ofatumumab in Treatment-Naïve Patients With MS

ByStephen L. Hauser, MD

September 22nd 2020

The director of the UCSF Weill Institute for Neuroscience offered his perspective on data presented at MS Virtual suggesting ofatumumab’s benefit in patients with MS who were treatment naïve.